Satellite Bio

Satellite Bio

Private
Watertown, MassachusettsHealthcare & Life Scienceshttps://www.satellite.bio

Last Round

Series A

Apr 20, 2022

Total Funding Raised

$110M

Momentum Score

50 /100

Company Overview

Satellite Bio is a biotechnology company that develops innovative cell therapies through proprietary, off-the-shelf, implantable satellite organs aimed at treating complex diseases and improving patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

tissue therapeuticsregenerative medicineimplantable tissuestissue implantsbioengineered tissuescell therapytissue engineeringbioprintingSAT platformliver disease therapyorgan repairorgan failure treatmentallogeneic therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Satellite Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Satellite Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 20, 2022

Key People

Founding team and executive leadership

Tom Lowery

Chief Technology Officer President

Executive Team

Satellite Bio Investors

Notable investors and investment history

InvestorRounds
S32Series A
aMoon GrowthSeries A
Waterman VenturesSeries A
Catalio Capital ManagementSeries A
Waterman VenturesSeries A
Polaris PartnersSeries A, Seed
Polaris Innovation FundSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 79% MoM to 1.5K.

  • Jan 4, 2026

    Steven Altschuler appointed as Chair of the Board of Directors.

Satellite Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Satellite Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Satellite Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts
Employee Range22
Year Founded2019
Last FundingApr 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.